Novavax to Participate in Upcoming Investor Conferences
Novavax (NASDAQ: NVAX) has announced its participation in two major upcoming investor conferences in June 2025. The company will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2025, from 2:00-2:30 PM ET in New York. Additionally, Novavax will deliver a presentation at the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, from 2:00-2:35 PM ET in Miami Beach.
Both events will be webcasted and available on Novavax's investor relations website at ir.novavax.com, with replays accessible for 30 days following the events.
Novavax (NASDAQ: NVAX) ha annunciato la sua partecipazione a due importanti conferenze per investitori previste per giugno 2025. L'azienda prenderà parte a una tavola rotonda informale durante la Jefferies Global Healthcare Conference il 4 giugno 2025, dalle 14:00 alle 14:30 ET a New York. Inoltre, Novavax terrà una presentazione alla 46ª Conferenza Globale Annuale sul Settore Sanitario di Goldman Sachs l'11 giugno 2025, dalle 14:00 alle 14:35 ET a Miami Beach.
Entrambi gli eventi saranno trasmessi in diretta streaming e disponibili sul sito dedicato agli investitori di Novavax all'indirizzo ir.novavax.com, con repliche accessibili per 30 giorni dopo la conclusione degli eventi.
Novavax (NASDAQ: NVAX) ha anunciado su participación en dos importantes conferencias para inversores que tendrán lugar en junio de 2025. La compañía participará en una charla informal en la Jefferies Global Healthcare Conference el 4 de junio de 2025, de 2:00 a 2:30 PM ET en Nueva York. Además, Novavax realizará una presentación en la 46ª Conferencia Anual Global de Salud de Goldman Sachs el 11 de junio de 2025, de 2:00 a 2:35 PM ET en Miami Beach.
Ambos eventos serán transmitidos en línea y estarán disponibles en el sitio web de relaciones con inversionistas de Novavax en ir.novavax.com, con repeticiones accesibles durante 30 días después de los eventos.
노바백스 (NASDAQ: NVAX)는 2025년 6월에 열리는 두 건의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 2025년 6월 4일 뉴욕에서 오후 2시부터 2시 30분(동부시간)까지 제프리스 글로벌 헬스케어 컨퍼런스에서 파이어사이드 채팅에 참여합니다. 또한, 노바백스는 2025년 6월 11일 마이애미 비치에서 오후 2시부터 2시 35분(동부시간)까지 골드만 삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에서 발표를 진행할 예정입니다.
두 행사 모두 웹캐스트로 중계되며, 노바백스 투자자 관계 웹사이트 ir.novavax.com에서 시청할 수 있고, 행사 종료 후 30일간 다시보기 서비스를 제공합니다.
Novavax (NASDAQ : NVAX) a annoncé sa participation à deux grandes conférences pour investisseurs prévues en juin 2025. La société prendra part à une discussion informelle lors de la Jefferies Global Healthcare Conference le 4 juin 2025, de 14h00 à 14h30 (heure de l’Est) à New York. De plus, Novavax fera une présentation lors de la 46e conférence annuelle mondiale sur la santé de Goldman Sachs le 11 juin 2025, de 14h00 à 14h35 (heure de l’Est) à Miami Beach.
Les deux événements seront diffusés en webdiffusion et disponibles sur le site des relations investisseurs de Novavax à l’adresse ir.novavax.com, avec des replays accessibles pendant 30 jours après les événements.
Novavax (NASDAQ: NVAX) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am 4. Juni 2025 von 14:00 bis 14:30 Uhr ET in New York an einem Fireside Chat auf der Jefferies Global Healthcare Conference teilnehmen. Außerdem wird Novavax am 11. Juni 2025 von 14:00 bis 14:35 Uhr ET in Miami Beach eine Präsentation auf der 46. jährlichen globalen Gesundheitskonferenz von Goldman Sachs halten.
Beide Veranstaltungen werden per Webcast übertragen und sind auf der Investor-Relations-Website von Novavax unter ir.novavax.com verfügbar, mit Wiedergaben, die 30 Tage nach den Veranstaltungen zugänglich sind.
- None.
- None.
Jefferies Global Healthcare Conference: | |
Fireside Chat | |
Date: | Wednesday, June 4, 2025 |
Time: | 2:00 – 2:30 p.m. Eastern Time (ET) |
Location: |
Goldman Sachs 46th Annual Global Healthcare Conference: | |
Presentation | |
Date: | Wednesday, June 11, 2025 |
Time: | 2:00 – 2:35 p.m. ET |
Location: |
A webcast of the fireside chat and presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcasts will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-investor-conferences-302467664.html
SOURCE Novavax, Inc.